Aktie A0M4V4 CHANGMAO BIOCHEMICAL ENGINEERING COMPANY LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Changmao Biochemical Engineering Company Limited

Aktien

A0M4V4

CNE100000106

954

Markt geschlossen - Hong Kong S.E.
Andere Börsenplätze
 10:08:17 17.05.2024 		% 5 Tage % 1. Jan.
0.43 HKD 0.00% Intraday Chart für Changmao Biochemical Engineering Company Limited -2.27% -27.12%
26.03. Changmao Biochemical Engineering Company Limited berichtet über die Ergebnisse für das am 31. Dezember 2023 endende Geschäftsjahr CI
29.02. Changmao Biochemical Engineering wird 2023 in den Verlust rutschen MT

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Changmao Biochemical Engineering Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023
Changmao Biochemical Engineering to Swing to Loss in 2023
Changmao Biochemical Engineering Company Limited Provides Earnings Guidance for the Year December 31, 2023
Changmao Biochemical Unit Seeks 200 Million Yuan Bank Loan to Boost Factory Capacity
Changmao Biochemical Engineering’s Profit Down 90% in H1
Changmao Biochemical Engineering Company Limited Reports Earnings Results for the Half Year Ended June 30, 2023
Changmao Biochemical Engineering's Profit to Drop in H1
Changmao Biochemical Engineering Company Limited Provides Consolidated Net Profit Attributable Guidance for the Six Months Ended 30 June 2023
Changmao Biochemical Engineering Company Limited approves Final Dividend for the Year Ended 31 December 2022, Payable on 18 July 2023
Changmao Biochemical Engineering Company Limited Recommends Final Dividend for the Year Ended 31 December 2022, Payable on 18 July 2023
Changmao Biochemical Engineering Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022
Changmao Biochemical Engineering Company Limited Announces Change of Chairman of Remuneration and Appraisal Committee
Changmao Biochemical Sees Rise in FY22 Profit
Changmao Biochemical Engineering Company Limited Provides Earnings Guidance for the Year 2022
Changmao Biochemical Engineering Eyes Secondary Listing in Shenzhen
Changmao Biochemical Engineering Company Limited Announces Appointment of Ms. Cheng Mun Wah as Independent Non-Executive Director and Chairman of Audit Committee, and Member of Remuneration Committee and Nomination Committee
Changmao Biochemical Engineering's H1 Net Profit Jumps to $6 Million
Changmao Biochemical Engineering Company Limited Reports Earnings Results for the Half Year Ended June 30, 2022
Changmao Biochemical Sees Significant Increase in H1 Profit
Changmao Biochemical Engineering Company Limited Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2022
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A0M4V4 Aktie
  4. Nachrichten Changmao Biochemical Engineering Company Limited
  5. Andere Sprachen